Transforming Lives Through Genetic Discovery
We seek to make a big difference in genetic disorders. At BioMarin, through our unparalleled expertise in genetics and molecular biology, we will continue to develop targeted therapies that address the root cause of the conditions we seek to treat. Applying our knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most.
Fast Facts
>$2 Billion
in 2022 FY Total Revenues
78 Countries
Commercial Footprint
World-class Capabilities
Manufacturing, R&D, Regulatory, and Commercial
"Core 4" Product Framework
Genetic, Targeted, Assessable, Transformational
Q3 2023
